Substantial doubt about the company's ability to continue as a going concern.
“While the Company believes in the viability of its strategy to generate revenues and in its ability to raise additional funds, there can be no assurances to that effect and there is a substantial doubt about the Company's ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon the Company's ability to further implement its business plan and generate revenues and raise capital.”View the 10-Q filed May 26, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The closing range uses available history since Dec 30, 2025; less than a full year is stored.
T-REX Acquisition Corp. delayed its annual filing for the year ended June 30, 2026 because of delays completing its financial statements and anticipated no significant change in results of operations from the corresponding period for the last fiscal year.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TRXA
this stock
T-REX Acquisition Corp.
|
$15.68M | -60.6% | +104.7% | — | 0.0% |
|
VYLR
Vylor Inc.
|
$48.09B | — | — | — | 2.1% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$652.61M | +3.5% | — | — | 0.0% |
|
EVAC
EQV Ventures Acquisition Corp. II
|
$606.10M | +3.4% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
T-REX Acquisition Corp. delayed its annual filing for the year ended June 30, 2026 because of delays completing its financial statements and anticipated no significant change in results of operations from the corresponding period for the last fiscal year.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TRXA | -24.4% | -58.7% | — | +0.0% | -60.6% |
| SPY | +0.1% | -3.3% | +2.6% | -0.4% | +10.4% |
| vs SPY | -24.4% | -55.5% | — | +0.4% | -71.0% |
